The Home Depot Inc. (NYSE: HD) reported better-than-expected revenue and earnings for the fourth quarter of 2019. Analysts had projected earnings of $2.10 per share on revenue of $25.78 billion. Shares were up 2.5% in premarket hours on Tuesday.
Total sales were $25.8 billion compared to $26.5 billion reported a year ago. Last year’s topline results benefited from an extra week of operations, which contributed around $1.7 billion in sales.
Net earnings were $2.5 billion, or $2.28 per share, compared to $2.3 billion, or $2.09 per share, in the prior-year quarter.
Comparable sales increased 5.2% and comp sales in the US increased 5.3%. Customer transactions declined 6.4% during the quarter while average ticket and sales per retail square foot increased 4.1% and 2.8% respectively.
The company stated that its strategic initiatives are yielding value and that sales have grown by over $9 billion through the second year of the One Home Depot investment program.
Earlier this month, the retailer said it is planning to hire 80,000 associates for spring, which is its busiest season of the year. Most of the part-time workers will be staffed in the garden center, with the aim of helping customers with their spring projects.
In December, Home Depot had provided preliminary 2020 guidance which was below analysts’ expectations and this caused the stock to drop at the time.
For fiscal year 2020, the company expects total sales growth of approx. 3.5-4%. Comparable sales is expected to grow approx. 3.5-4%. Diluted EPS is expected to grow approx. 2% to $10.45. Home Depot plans to open six new stores during the year.
The board of directors approved a 10% increase in the quarterly dividend to $1.50 per share, which amounts to an annual dividend of $6.00 per share. The dividend is payable on March 26, 2020 to shareholders of record on March 12, 2020.
At the end of the fourth quarter, Home Depot operated a total of 2,291 retail stores in all 50 states, the District of Columbia, Puerto Rico, the US Virgin Islands, Guam, 10 Canadian provinces and Mexico.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
